Allogene Therapeutics Inc Net Asset Quality Index
Allogene Therapeutics Inc net asset quality index. Allogene Therapeutics Inc (ALLO) has a Net Asset Quality Index of 71.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $439.77 Million minus total liabilities of $124.44 Million yields net assets of $315.33 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Allogene Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Allogene Therapeutics Inc (2018–2024)
Net asset quality index of Allogene Therapeutics Inc from 2018 to 2024. This chart shows how Allogene Therapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the index stands at 71.7%, representing net assets of $315.33 Million against total assets of $439.77 Million USD. Check Allogene Therapeutics Inc (ALLO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Allogene Therapeutics Inc Net Asset Quality Index by Year (2018–2024)
Allogene Therapeutics Inc net asset quality index by year from 2018 to 2024. The table below presents the year-by-year Net Asset Quality Index for Allogene Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ALLO company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 76.9% | $422.18 Million | $548.71 Million | $126.53 Million | ▼ -2.7 pp |
| 2023 | 79.7% | $512.23 Million | $642.84 Million | $130.60 Million | ▼ -1.5 pp |
| 2022 | 81.2% | $666.88 Million | $821.58 Million | $154.70 Million | ▼ -6.9 pp |
| 2021 | 88.0% | $925.20 Million | $1.05 Billion | $125.63 Million | ▲ +0.1 pp |
| 2020 | 87.9% | $1.08 Billion | $1.23 Billion | $148.21 Million | ▲ +0.3 pp |
| 2019 | 87.6% | $629.02 Million | $717.80 Million | $88.78 Million | ▼ -3.2 pp |
| 2018 | 90.9% | $703.16 Million | $773.86 Million | $70.69 Million | — |